Free tool
Healthcare stocks
We cover 614 companies in the Healthcare sector. The median market value in the group is $76.45M. Across the group, the median move over the past trading day is +0.85%. 52% of the 598 with a 200-day average trade above it. Price change over the past year runs from −85.7% to +178.0% across the middle 80 percent of the group, with a median of −8.0%. Across the group, 4 companies currently carry a tier A volume signal.
Other lists in this group
Table
614 of 2,199 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.85% |
| PFE | Pfizer Inc. | $159.42B | Large cap | +19.52% |
| DHR | Danaher Corporation | $151.82B | Large cap | +4.52% |
| VRTX | Vertex Pharmaceuticals Incorporated | $140.04B | Large cap | +42.14% |
| BMY | Bristol-Myers Squibb Company | $138.74B | Large cap | +49.31% |
| ISRG | Intuitive Surgical, Inc. | $133.22B | Large cap | −20.62% |
| SYK | Stryker Corporation | $126.81B | Large cap | −14.79% |
| MDT | Medtronic plc | $116.66B | Large cap | +1.33% |
| SNY | Sanofi | $110.27B | Large cap | −3.11% |
| MCK | McKesson Corporation | $105.52B | Large cap | +33.71% |
| GSK | GSK plc | $104.29B | Large cap | +34.79% |
| HCA | HCA Healthcare, Inc. | $95.12B | Large cap | +6.96% |
| ELV | Elevance Health, Inc. | $86.50B | Large cap | +29.17% |
| REGN | Regeneron Pharmaceuticals, Inc. | $85.82B | Large cap | +46.21% |
| CI | The Cigna Group | $73.81B | Large cap | −5.62% |
| BSX | Boston Scientific Corporation | $72.26B | Large cap | −52.56% |
| ARGX | argenx SE | $63.78B | Large cap | +50.52% |
| MRNA | Moderna, Inc. | $63.41B | Large cap | +526.55% |
| COR | Cencora, Inc. | $62.60B | Large cap | +14.44% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +21.77% |
| CAH | Cardinal Health, Inc. | $55.33B | Large cap | +64.25% |
| EW | Edwards Lifesciences Corporation | $52.32B | Large cap | +12.38% |
| BDX | Becton, Dickinson and Company | $51.69B | Large cap | +26.17% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.24% |
| MDLN | Medline Inc. | $46.69B | Large cap | −13.07% |
| HUM | Humana Inc. | $46.42B | Large cap | +32.71% |
| RVMD | Revolution Medicines, Inc. | $45.35B | Large cap | +492.60% |
| HLN | Haleon plc | $44.77B | Large cap | +6.56% |
| TEVA | Teva Pharmaceutical Industries Limited | $44.40B | Large cap | +110.26% |
| IDXX | IDEXX Laboratories, Inc. | $43.39B | Large cap | −14.24% |
| A | Agilent Technologies, Inc. | $43.33B | Large cap | +30.69% |
| IQV | IQVIA Holdings Inc. | $42.70B | Large cap | +37.97% |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +21.95% |
| WAT | Waters Corporation | $40.69B | Large cap | +38.63% |
| VEEV | Veeva Systems Inc. | $40.09B | Large cap | −13.47% |
| ALC | Alcon Inc. | $35.47B | Large cap | −8.71% |
| RPRX | Royalty Pharma plc | $35.44B | Large cap | +75.10% |
| RMD | ResMed Inc. | $34.13B | Large cap | −16.58% |
| ILMN | Illumina, Inc. | $33.97B | Large cap | +125.76% |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +17.38% |
| GEHC | GE HealthCare Technologies Inc. | $33.62B | Large cap | −0.78% |
| BIIB | Biogen Inc. | $32.62B | Large cap | +61.90% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −45.88% |
| CNC | Centene Corporation | $32.11B | Large cap | +123.52% |
| ZTS | Zoetis Inc. | $31.94B | Large cap | −49.59% |
| BNTX | BioNTech SE | $28.65B | Large cap | +8.55% |
| MTD | Mettler-Toledo International Inc. | $28.10B | Large cap | +8.72% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +23.25% |
| INSM | Insmed Incorporated | $27.07B | Large cap | −3.45% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.70% |
| PHG | Koninklijke Philips N.V. | $26.81B | Large cap | +3.60% |
| INCY | Incyte Corporation | $26.29B | Large cap | +53.04% |
| ROIV | Roivant Sciences Ltd. | $26.26B | Large cap | +213.32% |
| WST | West Pharmaceutical Services, Inc. | $24.52B | Large cap | +41.31% |
| STE | STERIS plc | $23.05B | Large cap | −4.35% |
| GH | Guardant Health, Inc. | $21.90B | Large cap | +166.52% |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +54.57% |
| GMAB | Genmab A/S | $21.42B | Large cap | +41.34% |
| VTRS | Viatris Inc. | $19.20B | Large cap | +62.88% |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.12B | Large cap | −5.86% |
| MEDP | Medpace Holdings, Inc. | $17.31B | Large cap | +31.55% |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | +108.87% |
| ASND | Ascendis Pharma A/S | $16.59B | Large cap | +32.89% |
| BBIO | BridgeBio Pharma, Inc. | $15.85B | Large cap | +70.01% |
| SOLV | Solventum Corporation | $15.59B | Large cap | +25.92% |
| NBIX | Neurocrine Biosciences, Inc. | $15.59B | Large cap | +14.46% |
| COO | The Cooper Companies, Inc. | $14.25B | Large cap | −0.60% |
| CRL | Charles River Laboratories International, Inc. | $14.21B | Large cap | +81.37% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +49.66% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +35.78% |
| BAX | Baxter International Inc. | $13.59B | Large cap | +7.91% |
| ICLR | ICON Public Limited Company | $13.38B | Large cap | −1.65% |
| CORT | Corcept Therapeutics Incorporated | $13.36B | Large cap | +79.56% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.80B | Large cap | +13.03% |
| PEN | Penumbra, Inc. | $12.75B | Large cap | +22.79% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +329.16% |
| FMS | Fresenius Medical Care AG | $12.51B | Large cap | −3.29% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +51.39% |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −9.45% |
| SNN | Smith & Nephew plc | $12.23B | Large cap | −19.49% |
| ELAN | Elanco Animal Health Incorporated | $12.20B | Large cap | +41.03% |
| EHC | Encompass Health Corporation | $11.85B | Large cap | −1.16% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $11.83B | Large cap | +24.24% |
| DVA | DaVita Inc. | $11.41B | Large cap | +29.47% |
| ALGN | Align Technology, Inc. | $11.34B | Large cap | +10.11% |
| BTSG | BrightSpring Health Services, Inc. | $11.32B | Large cap | +137.67% |
| TECH | Bio-Techne Corporation | $11.27B | Large cap | +28.12% |
| GMED | Globus Medical, Inc. | $11.14B | Large cap | +35.16% |
| CYTK | Cytokinetics, Incorporated | $10.77B | Large cap | +109.29% |
| AXSM | Axsome Therapeutics, Inc. | $10.76B | Large cap | +76.67% |
| GKOS | Glaukos Corporation | $10.70B | Large cap | +98.13% |
| SMMT | Summit Therapeutics Inc. | $10.66B | Large cap | −49.14% |
| IONS | Ionis Pharmaceuticals, Inc. | $10.56B | Large cap | +52.01% |
| KRYS | Krystal Biotech, Inc. | $10.54B | Large cap | +142.69% |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +202.82% |
| BIO | Bio-Rad Laboratories, Inc. | $10.45B | Large cap | +31.26% |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +5.44% |
| MOH | Molina Healthcare, Inc. | $10.42B | Large cap | +13.96% |
| UHS | Universal Health Services, Inc. | $10.40B | Large cap | −4.14% |
| ABVX | ABIVAX Société Anonyme | $10.29B | Large cap | +52.25% |
| RDY | Dr. Reddy's Laboratories Limited | $10.28B | Large cap | −14.66% |
| PRAX | Praxis Precision Medicines, Inc. | $10.28B | Large cap | +684.02% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +49.84% |
| HSIC | Henry Schein, Inc. | $10.21B | Large cap | +30.93% |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +265.05% |
| PTGX | Protagonist Therapeutics, Inc. | $10.01B | Large cap | +164.75% |
| PODD | Insulet Corporation | $9.92B | Mid cap | −56.52% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +67.40% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| AVTR | Avantor, Inc. | $9.75B | Mid cap | +9.16% |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +85.10% |
| TWST | Twist Bioscience Corporation | $9.50B | Mid cap | +452.83% |
| SYRE | Spyre Therapeutics, Inc. | $9.32B | Mid cap | +547.53% |
| PCVX | Vaxcyte, Inc. | $9.09B | Mid cap | +100.62% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −10.74% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +182.02% |
| IMVT | Immunovant, Inc. | $8.95B | Mid cap | +192.14% |
| HQY | HealthEquity, Inc. | $8.83B | Mid cap | +20.55% |
| BRKR | Bruker Corporation | $8.66B | Mid cap | +64.93% |
| ATR | AptarGroup, Inc. | $8.57B | Mid cap | −2.35% |
| TGTX | TG Therapeutics, Inc. Common Stock | $8.48B | Mid cap | +96.32% |
| TXG | 10x Genomics, Inc. | $8.43B | Mid cap | +359.99% |
| ALKS | Alkermes plc | $8.26B | Mid cap | +69.69% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +14.26% |
| HIMS | Hims & Hers Health, Inc. | $7.41B | Mid cap | −26.15% |
| CAI | Caris Life Sciences, Inc. | $7.38B | Mid cap | −27.21% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +63.19% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +19.61% |
| SRRK | Scholar Rock Holding Corporation | $7.09B | Mid cap | +74.77% |
| PACS | PACS Group, Inc. | $7.00B | Mid cap | +272.69% |
| CGON | CG Oncology, Inc. | $7.00B | Mid cap | +210.58% |
| ORKA | Oruka Therapeutics, Inc. | $6.74B | Mid cap | +601.72% |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +79.61% |
| BLTE | Belite Bio, Inc | $6.51B | Mid cap | +154.13% |
| COGT | Cogent Biosciences, Inc. | $6.39B | Mid cap | +212.13% |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +168.53% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +138.24% |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.24B | Mid cap | +93.10% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.17B | Mid cap | +142.74% |
| BLCO | Bausch + Lomb Corporation | $6.16B | Mid cap | +18.72% |
| ERAS | Erasca, Inc. | $6.16B | Mid cap | +1016.98% |
| PTCT | PTC Therapeutics, Inc. Common Stock | $6.13B | Mid cap | +49.03% |
| DNTH | Dianthus Therapeutics, Inc. | $6.13B | Mid cap | +378.90% |
| STVN | Stevanato Group S.p.A. | $6.08B | Mid cap | +3.23% |
| TVTX | Travere Therapeutics, Inc. | $6.06B | Mid cap | +288.91% |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +10.45% |
| DFTX | Definium Therapeutics, Inc. | $6.02B | Mid cap | +354.92% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +36.58% |
| TFX | Teleflex Incorporated | $5.94B | Mid cap | +10.85% |
| CRSP | CRISPR Therapeutics AG | $5.89B | Mid cap | +12.51% |
| XENE | Xenon Pharmaceuticals Inc. | $5.85B | Mid cap | +58.42% |
| LGND | Ligand Pharmaceuticals Incorporated | $5.62B | Mid cap | +77.42% |
| MMED | MiniMed Group, Inc. | $5.60B | Mid cap | +2.33% |
| SHC | Sotera Health Company | $5.57B | Mid cap | +19.04% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | +3.32% |
| GRFS | Grifols, S.A. | $5.44B | Mid cap | −17.62% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.23B | Mid cap | +20.73% |
| HAE | Haemonetics Corporation | $4.93B | Mid cap | +96.13% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +102.62% |
| EWTX | Edgewise Therapeutics, Inc. | $4.80B | Mid cap | +209.16% |
| BLLN | BillionToOne, Inc. | $4.72B | Mid cap | −8.14% |
| LFST | LifeStance Health Group, Inc. | $4.69B | Mid cap | +127.83% |
| WAY | Waystar Holding Corp. | $4.64B | Mid cap | −32.56% |
| ICUI | ICU Medical, Inc. | $4.56B | Mid cap | +44.85% |
| DOCS | Doximity, Inc. | $4.51B | Mid cap | −62.74% |
| RLAY | Relay Therapeutics, Inc. | $4.51B | Mid cap | +486.04% |
| ELVN | Enliven Therapeutics, Inc. | $4.48B | Mid cap | +205.89% |
| CELC | Celcuity Inc. | $4.44B | Mid cap | +87.35% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +49.74% |
| NVST | Envista Holdings Corporation | $4.39B | Mid cap | +30.07% |
| LIVN | LivaNova PLC | $4.37B | Mid cap | +40.92% |
| HTFL | Heartflow, Inc. | $4.34B | Mid cap | +67.19% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.26% |
| INDV | Indivior Pharmaceuticals, Inc. | $4.24B | Mid cap | +49.81% |
| ADPT | Adaptive Biotechnologies Corporation | $4.19B | Mid cap | +107.18% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.17B | Mid cap | +340.71% |
| LEGN | Legend Biotech Corporation | $4.14B | Mid cap | −38.44% |
| TNGX | Tango Therapeutics, Inc. | $4.13B | Mid cap | +264.73% |
| MANE | Veradermics, Incorporated | $4.11B | Mid cap | +171.13% |
| IDYA | IDEAYA Biosciences, Inc. | $4.10B | Mid cap | +71.91% |
| IRTC | iRhythm Holdings, Inc. | $4.06B | Mid cap | −25.71% |
| ABCL | AbCellera Biologics Inc. | $4.05B | Mid cap | +195.51% |
| RCUS | Arcus Biosciences, Inc. | $4.02B | Mid cap | +211.03% |
| VKTX | Viking Therapeutics, Inc. | $3.99B | Mid cap | +32.19% |
| DNLI | Denali Therapeutics Inc. | $3.98B | Mid cap | +60.12% |
| TLX | Telix Pharmaceuticals Limited | $3.96B | Mid cap | −4.26% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +52.72% |
| IOVA | Iovance Biotherapeutics, Inc. | $3.82B | Mid cap | +233.60% |
| GRAL | GRAIL, Inc. | $3.69B | Mid cap | +150.69% |
| OGN | Organon & Co. | $3.61B | Mid cap | +52.78% |
| GPCR | Structure Therapeutics Inc. | $3.56B | Mid cap | +168.82% |
| QURE | uniQure N.V. | $3.54B | Mid cap | +228.30% |
| OPCH | Option Care Health, Inc. | $3.54B | Mid cap | −15.75% |
| VCYT | Veracyte, Inc. Common Stock | $3.54B | Mid cap | +49.04% |
| NHC | National HealthCare Corporation | $3.52B | Mid cap | +103.48% |
| PLSE | Pulse Biosciences, Inc. | $3.50B | Mid cap | +197.94% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +196.22% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.33B | Mid cap | +275.00% |
| MBX | MBX Biosciences, Inc. | $3.30B | Mid cap | +394.02% |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.27B | Mid cap | +10.69% |
| WRBY | Warby Parker Inc. | $3.24B | Mid cap | −0.61% |
| CLDX | Celldex Therapeutics, Inc. | $3.24B | Mid cap | +87.96% |
| TMDX | TransMedics Group, Inc. | $3.23B | Mid cap | −18.59% |
| BEAM | Beam Therapeutics Inc. | $3.21B | Mid cap | +88.75% |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.20B | Mid cap | +26.21% |
| IRON | Disc Medicine, Inc. | $3.16B | Mid cap | +38.71% |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.12B | Mid cap | +58.44% |
| ALMS | Alumis Inc. | $2.98B | Mid cap | +388.98% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +82.91% |
| ZLAB | Zai Lab Limited | $2.94B | Mid cap | −23.10% |
| BKD | Brookdale Senior Living Inc. | $2.91B | Mid cap | +59.90% |
| SLS | SELLAS Life Sciences Group, Inc. | $2.89B | Mid cap | +637.70% |
| ALHC | Alignment Healthcare, Inc. | $2.82B | Mid cap | −12.77% |
| ACHC | Acadia Healthcare Company, Inc. | $2.78B | Mid cap | +34.73% |
| RGC | Regencell Bioscience Holdings Limited | $2.74B | Mid cap | −54.89% |
| VRDN | Viridian Therapeutics, Inc. | $2.74B | Mid cap | +30.21% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +56.96% |
| NRIX | Nurix Therapeutics, Inc. | $2.73B | Mid cap | +178.70% |
| PRVA | Privia Health Group, Inc. | $2.71B | Mid cap | −0.93% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +237.59% |
| CDNA | CareDx, Inc. | $2.63B | Mid cap | +298.43% |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.62B | Mid cap | +2.09% |
| PHVS | Pharvaris N.V. | $2.62B | Mid cap | +57.76% |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.61B | Mid cap | −9.60% |
| WGS | GeneDx Holdings Corp. | $2.61B | Mid cap | −28.28% |
| PGEN | Precigen, Inc. | $2.60B | Mid cap | +82.91% |
| TRVI | Trevi Therapeutics, Inc. | $2.56B | Mid cap | +146.57% |
| VERA | Vera Therapeutics, Inc. | $2.54B | Mid cap | +65.32% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +107.86% |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +176.20% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.51B | Mid cap | +17.16% |
| BHC | Bausch Health Companies Inc. | $2.50B | Mid cap | −7.81% |
| NUVB | Nuvation Bio Inc. | $2.49B | Mid cap | +146.53% |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +316.68% |
| ATRC | AtriCure, Inc. | $2.48B | Mid cap | +28.65% |
| PBH | Prestige Consumer Healthcare Inc. | $2.46B | Mid cap | −21.64% |
| RAPP | Rapport Therapeutics, Inc. | $2.46B | Mid cap | +249.76% |
| BFLY | Butterfly Network, Inc. | $2.41B | Mid cap | +483.23% |
| OCUL | Ocular Therapeutix, Inc. | $2.39B | Mid cap | −8.34% |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +42.20% |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +37.69% |
| MLYS | Mineralys Therapeutics, Inc. | $2.32B | Mid cap | +78.70% |
| COAG | Hemab Therapeutics Holdings, Inc. | $2.32B | Mid cap | +46.03% |
| ALMR | Alamar Biosciences, Inc. | $2.29B | Mid cap | +50.09% |
| GENB | Generate Biomedicines, Inc. | $2.27B | Mid cap | +61.11% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.27B | Mid cap | +4.09% |
| URGN | UroGen Pharma Ltd. | $2.27B | Mid cap | +150.59% |
| ADUS | Addus HomeCare Corporation | $2.26B | Mid cap | +3.81% |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +9.42% |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.23B | Mid cap | +38.03% |
| VCEL | Vericel Corporation | $2.21B | Mid cap | +20.76% |
| ZBIO | Zenas BioPharma, Inc. | $2.20B | Mid cap | +103.93% |
| CLOV | Clover Health Investments, Corp. | $2.19B | Mid cap | +56.14% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +58.21% |
| XRAY | DENTSPLY SIRONA Inc. | $2.19B | Mid cap | −21.70% |
| NEO | NeoGenomics, Inc. | $2.19B | Mid cap | +160.31% |
| XNCR | Xencor, Inc. Common Stock | $2.18B | Mid cap | +265.79% |
| BHVN | Biohaven Ltd. | $2.17B | Mid cap | −3.75% |
| STOK | Stoke Therapeutics, Inc. | $2.16B | Mid cap | +77.32% |
| ESTA | Establishment Labs Holdings Inc. | $2.15B | Mid cap | +77.45% |
| KLRA | Kailera Therapeutics, Inc. | $2.14B | Mid cap | −31.73% |
| ADMA | ADMA Biologics, Inc. | $2.14B | Mid cap | −42.86% |
| PVLA | Palvella Therapeutics, Inc. | $2.14B | Mid cap | +195.71% |
| HCM | HUTCHMED (China) Limited | $2.13B | Mid cap | −23.04% |
| NBTX | Nanobiotix S.A. | $2.11B | Mid cap | +321.42% |
| PIII | P3 Health Partners Inc. | $2.06B | Mid cap | +35.72% |
| CMPS | COMPASS Pathways plc | $2.06B | Mid cap | +224.89% |
| NVCR | NovoCure Limited | $2.05B | Mid cap | +50.60% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +26.87% |
| TSHA | Taysha Gene Therapies, Inc. | $2.02B | Mid cap | +112.33% |
| PRGO | Perrigo Company plc | $2.01B | Mid cap | −36.97% |
| KLRS | Kalaris Therapeutics, Inc. | $99.98M | Micro cap | +67.33% |
| GOSS | Gossamer Bio, Inc. | $99.97M | Micro cap | −91.33% |
| ATRA | Atara Biotherapeutics, Inc. | $98.77M | Micro cap | −19.61% |
| PARK | Park Dental Partners, Inc. | $98.64M | Micro cap | +99.61% |
| CGTX | Cognition Therapeutics, Inc. | $97.95M | Micro cap | −67.61% |
| FBIO | Fortress Biotech, Inc. | $94.38M | Micro cap | +23.58% |
| PLYX | Polaryx Therapeutics, Inc. | $94.21M | Micro cap | −94.66% |
| ALDX | Aldeyra Therapeutics, Inc. | $93.51M | Micro cap | −73.14% |
| ACRV | Acrivon Therapeutics, Inc. | $93.42M | Micro cap | +63.91% |
| HYPR | Hyperfine, Inc. | $92.24M | Micro cap | −30.42% |
| DWTX | Dogwood Therapeutics, Inc. | $91.10M | Micro cap | −47.04% |
| CVRX | CVRx, Inc. | $89.78M | Micro cap | −54.77% |
| RLYB | Rallybio Corporation | $89.67M | Micro cap | +262.65% |
| ICCC | ImmuCell Corporation | $89.37M | Micro cap | +61.58% |
| ACH | Accendra Health, Inc. | $89.21M | Micro cap | −77.39% |
| TENX | Tenax Therapeutics, Inc. | $86.82M | Micro cap | −60.81% |
| SERA | Sera Prognostics, Inc. | $86.00M | Micro cap | −17.42% |
| MAIA | MAIA Biotechnology, Inc. | $85.78M | Micro cap | −10.76% |
| CTOR | Citius Oncology, Inc. | $85.68M | Micro cap | −57.14% |
| ECOR | electroCore, Inc. | $85.38M | Micro cap | +79.70% |
| CING | Cingulate Inc. | $85.36M | Micro cap | +39.60% |
| ACET | Adicet Bio, Inc. | $84.25M | Micro cap | −20.89% |
| VRCA | Verrica Pharmaceuticals Inc. | $83.66M | Micro cap | −17.53% |
| RPID | Rapid Micro Biosystems, Inc. | $83.26M | Micro cap | −37.12% |
| GANX | Gain Therapeutics, Inc. | $83.14M | Micro cap | +3.53% |
| OKYO | OKYO Pharma Limited | $81.87M | Micro cap | −35.80% |
| TELO | Telomir Pharmaceuticals, Inc. | $81.15M | Micro cap | −19.18% |
| ATHE | Alterity Therapeutics Limited | $81.02M | Micro cap | −12.35% |
| OM | Outset Medical, Inc. | $80.92M | Micro cap | −68.62% |
| DH | Definitive Healthcare Corp. | $80.51M | Micro cap | −81.10% |
| CRDF | Cardiff Oncology, Inc. | $79.35M | Micro cap | −53.85% |
| ELTX | Elicio Therapeutics, Inc. | $79.11M | Micro cap | −72.71% |
| ANVS | Annovis Bio, Inc. | $77.54M | Micro cap | −18.75% |
| MNOV | MediciNova, Inc. | $77.28M | Micro cap | +18.94% |
| APLM | Apollomics, Inc. | $76.75M | Micro cap | +318.64% |
| OSTX | OS Therapies Incorporated | $76.68M | Micro cap | −24.66% |
| NRXS | NeurAxis, Inc. | $76.23M | Micro cap | +137.80% |
| ZTEK | Zentek Ltd. | $76.16M | Micro cap | −7.46% |
| LONA | LeonaBio, Inc. | $75.47M | Micro cap | +95.37% |
| PLRX | Pliant Therapeutics, Inc. | $73.69M | Micro cap | −23.49% |
| IBIO | iBio, Inc. | $73.03M | Micro cap | +72.94% |
| DRIO | DarioHealth Corp. | $72.42M | Micro cap | −32.82% |
| FBIOP | Fortress Biotech, Inc. | $71.45M | Micro cap | +141.55% |
| SPRO | Spero Therapeutics, Inc. | $70.76M | Micro cap | −33.51% |
| MDXH | MDxHealth SA | $70.73M | Micro cap | −83.84% |
| XBIT | XBiotech Inc. | $70.43M | Micro cap | −28.13% |
| EXOZ | eXoZymes, Inc. | $69.89M | Micro cap | −19.12% |
| PMVP | PMV Pharmaceuticals, Inc. | $69.76M | Micro cap | −8.10% |
| INCR | InterCure Ltd. | $69.65M | Micro cap | +254.22% |
| CSBR | Champions Oncology, Inc. | $69.19M | Micro cap | −29.46% |
| RNTX | Rein Therapeutics Inc. | $69.01M | Micro cap | −32.20% |
| NNOX | Nano-X Imaging Ltd. | $67.82M | Micro cap | −77.81% |
| INMB | INmune Bio Inc. | $67.44M | Micro cap | +8.48% |
| BOLD | Boundless Bio, Inc. | $67.33M | Micro cap | +160.18% |
| SER | Serina Therapeutics, Inc. | $66.80M | Micro cap | −52.13% |
| HYFT | MindWalk Holdings Corp. | $66.72M | Micro cap | −48.55% |
| RNXT | RenovoRx, Inc. | $64.08M | Micro cap | +58.13% |
| TLPH | Talphera, Inc. | $63.84M | Micro cap | +108.77% |
| IMA | ImageneBio, Inc. | $63.80M | Micro cap | −60.78% |
| HRTX | Heron Therapeutics, Inc. | $61.34M | Micro cap | −76.59% |
| INKT | MiNK Therapeutics, Inc. | $60.32M | Micro cap | −21.89% |
| XLO | Xilio Therapeutics, Inc. | $59.75M | Micro cap | −7.35% |
| NTRB | Nutriband Inc. | $58.71M | Micro cap | −24.59% |
| MYO | Myomo, Inc. | $58.62M | Micro cap | +35.78% |
| DXR | Daxor Corporation | $58.38M | Micro cap | −7.83% |
| COCH | Envoy Medical, Inc. | $57.66M | Micro cap | −33.30% |
| SRTS | Sensus Healthcare, Inc. | $57.45M | Micro cap | +7.35% |
| IMMP | Immutep Limited | $56.28M | Micro cap | −77.54% |
| ATYR | aTyr Pharma, Inc. | $55.91M | Micro cap | −88.95% |
| GNTA | Genenta Science S.p.A. | $55.45M | Micro cap | −67.05% |
| PRPO | Precipio, Inc. | $55.23M | Micro cap | +117.41% |
| BTMD | biote Corp. | $53.56M | Micro cap | −51.08% |
| HYPD | Hyperion DeFi, Inc. | $52.99M | Micro cap | −44.10% |
| TCRX | TScan Therapeutics, Inc. | $51.87M | Micro cap | −58.23% |
| SCYX | SCYNEXIS, Inc. | $51.64M | Micro cap | +514.20% |
| TIL | Instil Bio, Inc. | $51.54M | Micro cap | −69.62% |
| MDAI | Spectral AI, Inc. | $51.50M | Micro cap | −19.70% |
| IBO | Impact BioMedical Inc. | $49.62M | Micro cap | −20.79% |
| POCI | Precision Optics Corporation, Inc. | $48.27M | Micro cap | −9.07% |
| NSRX | Nasus Pharma Ltd. | $48.01M | Micro cap | −48.69% |
| QTI | QT Imaging Holdings, Inc. | $47.42M | Micro cap | −90.73% |
| MCRB | Seres Therapeutics, Inc. | $46.81M | Micro cap | −74.00% |
| ALGS | Aligos Therapeutics, Inc. | $46.65M | Micro cap | −26.84% |
| GRCE | Grace Therapeutics, Inc. | $46.28M | Micro cap | −32.31% |
| FLNA | Filana Therapeutics, Inc. | $45.83M | Micro cap | −56.07% |
| NEPH | Nephros, Inc. | $45.83M | Micro cap | +0.72% |
| MGX | Metagenomi Therapeutics, Inc. | $45.71M | Micro cap | −35.64% |
| MREO | Mereo BioPharma Group plc | $44.97M | Micro cap | −83.82% |
| XTNT | Xtant Medical Holdings, Inc. | $44.88M | Micro cap | −50.02% |
| IXHL | Incannex Healthcare Inc. | $44.87M | Micro cap | −83.13% |
| TVGN | Tevogen Inc. | $44.34M | Micro cap | −84.85% |
| MLSS | Milestone Scientific Inc. | $43.04M | Micro cap | −17.80% |
| HOWL | Werewolf Therapeutics, Inc. | $42.93M | Micro cap | −35.04% |
| EDSA | Edesa Biotech, Inc. | $42.90M | Micro cap | +83.88% |
| ELUT | Elutia Inc. | $42.30M | Micro cap | −57.74% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $42.19M | Micro cap | −69.57% |
| PAVM | PAVmed Inc. | $40.78M | Micro cap | −64.04% |
| NSPR | InspireMD, Inc. | $40.75M | Micro cap | −61.66% |
| SNWV | SANUWAVE Health, Inc. | $40.17M | Micro cap | −89.05% |
| CNTX | Context Therapeutics Inc. | $40.00M | Micro cap | −50.13% |
| CRVO | CervoMed Inc. | $39.76M | Micro cap | −71.90% |
| BDMD | Baird Medical Investment Holdings Limited | $38.38M | Micro cap | −49.79% |
| PETS | PetMed Express, Inc. | $38.15M | Micro cap | −44.30% |
| DCGO | DocGo Inc. | $37.83M | Micro cap | −76.68% |
| CPHI | China Pharma Holdings, Inc. | $37.60M | Micro cap | −38.45% |
| LITS | Lite Strategy, Inc. | $35.73M | Micro cap | −79.00% |
| ONMD | OneMedNet Corporation | $34.98M | Micro cap | −23.14% |
| NSYS | Nortech Systems Incorporated | $34.79M | Micro cap | +42.57% |
| CCEL | Cryo-Cell International, Inc. | $34.67M | Micro cap | −0.92% |
| HBIO | Harvard Bioscience, Inc. | $34.37M | Micro cap | +51.60% |
| QNCX | Quince Therapeutics, Inc. | $34.05M | Micro cap | +95.76% |
| ATNM | Actinium Pharmaceuticals, Inc. | $33.88M | Micro cap | −39.66% |
| NNVC | NanoViricides, Inc. | $32.93M | Micro cap | −12.84% |
| BCTX | BriaCell Therapeutics Corp. | $32.80M | Micro cap | −49.67% |
| KYNB | Kyntra Bio, Inc. | $32.80M | Micro cap | −23.80% |
| MIRA | MIRA Pharmaceuticals, Inc. | $32.58M | Micro cap | −45.40% |
| ESLA | Estrella Immunopharma, Inc. | $31.97M | Micro cap | −24.41% |
| RMTI | Rockwell Medical, Inc. | $31.84M | Micro cap | +511.15% |
| ARAY | Accuray Incorporated | $31.78M | Micro cap | −82.83% |
| IGC | IGC Pharma, Inc. | $31.49M | Micro cap | −17.68% |
| TELA | TELA Bio, Inc. | $31.43M | Micro cap | −61.75% |
| YI | 111, Inc. | $31.05M | Micro cap | −46.31% |
| MODD | Modular Medical, Inc. | $30.89M | Micro cap | −83.38% |
| BYSI | BeyondSpring Inc. | $29.61M | Micro cap | −60.43% |
| GRDX | GridAI Technologies Corp. | $28.75M | Micro cap | +98.05% |
| EVAX | Evaxion A/S | $28.36M | Micro cap | +4.49% |
| OPTH | Optimi Health Corp. | $28.06M | Micro cap | −19.41% |
| LTRN | Lantern Pharma Inc. | $27.87M | Micro cap | −52.30% |
| DYAI | Dyadic International, Inc. | $27.68M | Micro cap | −20.57% |
| BEAT | HeartBeam, Inc. | $27.23M | Micro cap | −54.27% |
| NXTC | NextCure, Inc. | $27.05M | Micro cap | +13.33% |
| BRNS | Barinthus Biotherapeutics plc | $26.96M | Micro cap | −44.77% |
| PSTV | Plus Therapeutics Inc | $26.64M | Micro cap | −68.67% |
| ENLV | Enlivex Ltd. | $26.58M | Micro cap | +40.74% |
| ATOS | Atossa Therapeutics, Inc. | $26.35M | Micro cap | −76.49% |
| CVM | CEL-SCI Corporation | $26.03M | Micro cap | −85.98% |
| MRKR | Marker Therapeutics, Inc. | $25.34M | Micro cap | +20.63% |
| CLRB | Cellectar Biosciences, Inc. | $24.01M | Micro cap | −45.96% |
| JSPR | Jasper Therapeutics, Inc. | $23.96M | Micro cap | −75.67% |
| TXMD | TherapeuticsMD, Inc. | $23.96M | Micro cap | +105.41% |
| FEMY | Femasys Inc. | $23.87M | Micro cap | +453.40% |
| TVRD | Tvardi Therapeutics, Inc. | $23.74M | Micro cap | −93.77% |
| BTAI | BioXcel Therapeutics, Inc. | $23.23M | Micro cap | −85.62% |
| BFRI | Biofrontera Inc. | $22.43M | Micro cap | +63.77% |
| CTSO | Cytosorbents Corporation | $22.33M | Micro cap | −60.78% |
| RVP | Retractable Technologies, Inc. | $22.00M | Micro cap | −13.54% |
| COCP | Cocrystal Pharma, Inc. | $21.77M | Micro cap | −26.62% |
| LGVN | Longeveron Inc. | $21.68M | Micro cap | −12.71% |
| CCM | Concord Medical Services Holdings Limited | $21.49M | Micro cap | −10.65% |
| ABVC | ABVC BioPharma, Inc. | $21.32M | Micro cap | −72.70% |
| ALLR | Allarity Therapeutics, Inc. | $21.16M | Micro cap | +41.34% |
| LFWD | Lifeward Ltd. | $20.93M | Micro cap | −3.63% |
| NEUP | Neuphoria Therapeutics Inc. | $20.86M | Micro cap | −47.41% |
| QNTM | Quantum BioPharma Ltd. | $20.83M | Micro cap | −81.47% |
| COSM | Cosmos Health Inc. | $20.67M | Micro cap | −74.86% |
| PLRZ | Polyrizon Ltd. | $20.40M | Micro cap | +74.84% |
| NCEL | NewcelX Ltd. | $19.83M | Micro cap | −85.80% |
| PMI | Picard Medical, Inc. | $19.61M | Micro cap | +11.76% |
| RADX | Radiopharm Theranostics Limited | $19.55M | Micro cap | −55.71% |
| NMTC | NeuroOne Medical Technologies Corporation | $19.49M | Micro cap | −53.91% |
| HKPD | Cellyan Biotechnology Co., Ltd | $19.30M | Micro cap | −62.10% |
| VYNE | VYNE Therapeutics Inc | $19.07M | Micro cap | +8687.69% |
| KTTA | Pasithea Therapeutics Corp. | $18.71M | Micro cap | −21.90% |
| PTN | Palatin Technologies, Inc. | $18.45M | Micro cap | −2.72% |
| TPST | Tempest Therapeutics, Inc. | $18.36M | Micro cap | −89.50% |
| PLSM | Pulsenmore Ltd. | $18.14M | Micro cap | −62.09% |
| PLUR | Pluri Inc. | $17.91M | Micro cap | −71.43% |
| SCNX | Scienture Holdings, Inc. | $17.76M | Micro cap | −60.65% |
| BIVI | BioVie Inc. | $17.66M | Micro cap | +26.67% |
| LEXX | Lexaria Bioscience Corp. | $17.42M | Micro cap | +1004.76% |
| CYCN | Cyclerion Therapeutics, Inc. | $17.32M | Micro cap | +57.17% |
| BCDA | BioCardia, Inc. | $17.11M | Micro cap | −42.05% |
| CALC | CalciMedica, Inc. | $17.10M | Micro cap | −78.92% |
| LPCN | Lipocine Inc. | $16.98M | Micro cap | −28.81% |
| CMMB | Chemomab Therapeutics Ltd. | $16.85M | Micro cap | −33.91% |
| CTXR | Citius Pharmaceuticals, Inc. | $16.57M | Micro cap | −52.09% |
| PBM | Psyence Biomedical Ltd. | $16.29M | Micro cap | −96.62% |
| MDCX | Medicus Pharma Ltd. | $16.26M | Micro cap | −87.97% |
| INTS | Intensity Therapeutics, Inc. | $15.98M | Micro cap | −37.24% |
| DARE | Daré Bioscience, Inc. | $15.90M | Micro cap | −60.54% |
| LSTA | Lisata Therapeutics, Inc. | $15.68M | Micro cap | −31.23% |
| HIND | Vyome Holdings, Inc. | $15.65M | Micro cap | −80.23% |
| PASG | Passage Bio, Inc. | $15.54M | Micro cap | −35.38% |
| KALA | KALA BIO, Inc. | $15.38M | Micro cap | −99.81% |
| ADIL | Adial Pharmaceuticals, Inc. | $15.28M | Micro cap | −38.74% |
| RGNT | Regentis Biomaterials Ltd. | $15.17M | Micro cap | −72.13% |
| ADVB | Advanced Biomed Inc. | $15.17M | Micro cap | −4.38% |
| BNGO | Bionano Genomics, Inc. | $14.72M | Micro cap | −69.51% |
| AKTX | Akari Therapeutics, Plc | $14.54M | Micro cap | −77.77% |
| NRSN | NeuroSense Therapeutics Ltd. | $14.16M | Micro cap | −66.55% |
| ICU | SeaStar Medical Holding Corporation | $14.06M | Micro cap | −64.23% |
| PHIO | Phio Pharmaceuticals Corp. | $13.82M | Micro cap | −41.21% |
| GTBP | GT Biopharma, Inc. | $13.52M | Micro cap | −72.50% |
| CABR | Caring Brands, Inc. | $13.32M | Micro cap | +54.26% |
| HSCS | HeartSciences Inc. | $13.10M | Micro cap | −10.45% |
| IRIX | IRIDEX Corporation | $12.46M | Micro cap | −43.62% |
| BLRX | BioLineRx Ltd. | $12.45M | Micro cap | −25.97% |
| PDSB | PDS Biotechnology Corporation | $12.40M | Micro cap | −82.96% |
| ADGM | Adagio Medical Holdings, Inc. | $12.22M | Micro cap | −56.69% |
| HCTI | Healthcare Triangle, Inc. | $12.21M | Micro cap | −99.49% |
| SNTI | Senti Biosciences Holdings, Inc. | $12.17M | Micro cap | −75.42% |
| MBRX | Moleculin Biotech, Inc. | $11.90M | Micro cap | −95.75% |
| INAB | IN8bio, Inc. | $11.53M | Micro cap | −46.58% |
| KPRX | Kiora Pharmaceuticals, Inc. | $11.46M | Micro cap | −2.26% |
| MBAI | Check-Cap Ltd. | $11.11M | Micro cap | +1143.08% |
| GDTC | CytoMed Therapeutics Limited | $11.06M | Micro cap | −52.59% |
| VTGN | Vistagen Therapeutics, Inc. | $11.02M | Micro cap | −91.80% |
| ASBP | Aspire Biopharma Holdings, Inc. | $10.95M | Micro cap | −62.41% |
| TOVX | Theriva Biologics, Inc. | $10.90M | Micro cap | −45.33% |
| MTVA | MetaVia Inc. | $10.80M | Micro cap | −77.06% |
| BFRG | Bullfrog AI Holdings, Inc. | $10.76M | Micro cap | −52.84% |
| AEON | AEON Biopharma, Inc. | $10.57M | Micro cap | −70.77% |
| SINT | Sintx Technologies, Inc. | $10.40M | Micro cap | −54.91% |
| QNRX | Quoin Pharmaceuticals, Ltd. | $10.18M | Micro cap | −31.02% |
| APRE | Aprea Therapeutics, Inc. | $10.14M | Micro cap | −40.63% |
| LNAI | Lunai Bioworks Inc. | $9.97M | Micro cap | −87.99% |
| AMS | American Shared Hospital Services | $9.78M | Micro cap | −40.49% |
| LUCY | Lucyd, Inc | $9.64M | Micro cap | −45.96% |
| AZTR | Azitra, Inc. | $9.55M | Micro cap | −78.97% |
| FBLG | FibroBiologics, Inc. | $9.32M | Micro cap | −88.54% |
| IMRN | Immuron Limited | $9.20M | Micro cap | −36.84% |
| XBIO | Xenetic Biosciences, Inc. | $8.93M | Micro cap | +33.57% |
| IMNN | Imunon, Inc. | $8.92M | Micro cap | −73.86% |
| SKYE | Skye Bioscience, Inc. | $8.92M | Micro cap | −43.08% |
| WGRX | Wellgistics Health Inc | $8.85M | Micro cap | −96.30% |
| SNGX | Soligenix, Inc. | $8.81M | Micro cap | −87.06% |
| EVGN | Evogene Ltd. | $8.68M | Micro cap | −56.73% |
| XWEL | XWELL, Inc. | $8.63M | Micro cap | −9.45% |
| DRMA | Dermata Therapeutics, Inc. | $8.52M | Micro cap | −70.50% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.